Research-grade reagents for Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) — the betacoronavirus responsible for COVID-19. Spike protein (S1, S2, RBD, NTD) and Nucleocapsid (N) are primary targets for diagnostic development, vaccine research, and neutralizing antibody characterization. We offer recombinant/polyclonal/InVivoMAb antibodies, recombinant proteins, assay kits, validated for ELISA, WB, IHC, FCM, IF, Neutralization, SPR, Blocking. RUO
Why Researchers Choose abinScience
Recombinant Antibodies (136)Epitope-mapped clones for ELISA, WB, and immunoassay development. Suitable for diagnostic R&D and as reference standards.
Polyclonal Antibodies (12)Broad epitope recognition for Western blot and IHC detection. Validated for ELISA, WB, IHC, FCM, IF, Neutralization, SPR, Blocking.
InVivoMAb Functional-Grade (23)Low-endotoxin, azide-free antibodies for in vivo neutralization, passive immunization, and functional blocking studies.
Recombinant Proteins (109)His-tagged and Fc-tagged antigens validated for SDS-PAGE, WB, and ELISA. Suitable as immunogens, coating antigens, and assay standards.
Assay Kits (42)Ready-to-use ELISA kits for quantitative antigen or antibody detection with lot-specific validation data.
All products manufactured by AtaGenix Laboratories under ISO 9001 & ISO 13485 quality systems.
中文
English
한국어
日本語
Español
Français
Русский
